Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell proliferation inhibition in remitting multiple sclerosis CSF.

Fred C Westall1, Fredrick J Seil

  • 1Institute for Disease Research, Temecula, Calif. 92589, USA. fcwestallidr@adelphia.net

European Neurology
|June 15, 2006
PubMed
Summary

Cerebrospinal fluid (CSF) from multiple sclerosis (MS) patients in remission inhibits neuronal and glial cell proliferation. This inhibitory effect was not observed in active MS or control groups, suggesting a unique role for CSF in remission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myelin Antigens and Antimyelin Antibodies.

Antibodies (Basel, Switzerland)·2019
Same author

Circuit reorganization in cerebellar cultures after injury.

Neural regeneration research·2015
Same author

The changeable nervous system: studies on neuroplasticity in cerebellar cultures.

Neuroscience and biobehavioral reviews·2014
Same author

A response to "Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis".

Journal of neuroimmunology·2008
Same author

Abnormal hormonal control of gut hydrolytic enzymes causes autoimmune attack on the CNS by production of immune-mimic and adjuvant molecules: A comprehensive explanation for the induction of multiple sclerosis.

Medical hypotheses·2006
Same author

Molecular mimicry revisited: gut bacteria and multiple sclerosis.

Journal of clinical microbiology·2006

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system.
  • The role of cerebrospinal fluid (CSF) in the pathogenesis and progression of MS is not fully understood.
  • Cellular proliferation is a key process in both lesion formation and repair in neurological disorders.

Purpose of the Study:

  • To investigate the effect of CSF from MS patients in different disease stages on cellular proliferation.
  • To determine if CSF from MS patients impacts myelination.
  • To explore potential inhibitory factors in CSF related to neurodegenerative processes.

Main Methods:

  • Collection and analysis of CSF samples from multiple sclerosis patients (remission, relapsing, progressive, stationary) and controls.

Related Experiment Videos

  • Testing CSF for inhibition of cellular proliferation in neuronal and glial cell lines.
  • Assessing the effect of CSF on myelination using mouse organotypic cerebellar cultures.
  • Analysis of CSF from patients with Huntington's, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis.

    • Main Results:

    • Sixty percent of CSF samples from MS patients in remission inhibited neuronal and glial cell proliferation.
    • No inhibition was observed in CSF from relapsing or progressive MS patients (0/19).
    • Approximately 20% of CSF samples from Huntington's, Alzheimer's, and Parkinson's disease patients showed inhibition, but none from ALS patients or controls.

    Conclusions:

    • CSF from MS patients in remission possesses inhibitory properties against cellular proliferation.
    • This inhibitory effect appears specific to remission and is absent in active or progressive MS.
    • The findings suggest an active 'deactivation' process in MS lesions and a potential role for CSF factors in modulating neuroinflammation and neurodegeneration.